Michael Recht/LinkedIn
Nov 26, 2025, 14:52
WFH Committee Member Highlight: Michael Recht on the Effectiveness of Octocog Alfa in Haemophilia A
World Federation of Hemophilia (WFH) shared on LinkedIn:
” Real-world data tell a powerful story.
In a recent study Octocog Alfa (BAY 81-8973) has shown effectiveness for people with hemophilia A, including under-represented groups, in the ATHN dataset.”
WFH has shared a committee member highlight from Michael Recht.
Read the full article here.
Article: Effectiveness of Octocog Alfa (BAY 81-8973) to Treat People With Haemophilia A Enrolled in the ATHNdataset, Including Under-Represented Subgroups
Authors: Martin Chandler, Thomas Moulton, Lena Charafi, Jessica Charlet, Michael Recht
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests